FdaApplication
NDA 021039
Identifiers
- fda_app_no: NDA021039
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE |
| application_type | NDA |
| approval_date | 1999-04-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AGENERASE | AMPRENAVIR | 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;ORAL |
1 product